SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024732
Filing Date
2022-11-14
Accepted
2022-11-14 08:27:47
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prld-20220930.htm   iXBRL 10-Q 2901067
2 EX-10.1 prld-ex10_1.htm EX-10.1 961675
3 EX-31.1 prld-ex31_1.htm EX-31.1 21621
4 EX-31.2 prld-ex31_2.htm EX-31.2 21646
5 EX-32.1 prld-ex32_1.htm EX-32.1 12231
6 EX-32.2 prld-ex32_2.htm EX-32.2 12423
  Complete submission text file 0000950170-22-024732.txt   9287516

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prld-20220930_def.xml EX-101.DEF 158830
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prld-20220930_lab.xml EX-101.LAB 348881
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prld-20220930_cal.xml EX-101.CAL 35457
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prld-20220930_pre.xml EX-101.PRE 257910
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prld-20220930.xsd EX-101.SCH 37103
52 EXTRACTED XBRL INSTANCE DOCUMENT prld-20220930_htm.xml XML 1465764
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39527 | Film No.: 221380589
SIC: 2834 Pharmaceutical Preparations